This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sekar, N. Articles by Shechter, Y. Search for Related Content PubMed PubMed Citation Articles by Sekar, N. Articles by Shechter, Y.

Vanadate Elevates Lipogenicity of Starved Rat Adipose Tissue: Mechanism of Action¹

Department of Biological Chemistry, The Weizmann Institute of Science Rehovot-76100, Israel

Address all correspondence and requests for reprints to: Yoram Shechter, Department of Biological Chemistry, Weizmann Institute of Science, Rehovot-76100, Israel.

We have established an experimental system in rats in which the lipogenic capacity of adipose tissue was decreased in vivo by prolonged fasting, and restored in vitro by glucose together with insulin or vanadate. Incubation of fasted adipose explants for 5 h at 37 C with 2 mM glucose alone did not elevate lipogenic capacity. However, glucose with insulin (17 nM) or vanadate (100 µM), led, respectively, to 2.2- and 8- to 10-fold elevation. Actinomycin D (50 µM) completely blocked this increase, while low concentrations (ED₅₀ = 4.0 ± 0.4 µM) of vanadate potentiated it. Neither insulin nor vanadate elevated fasted adipose explants’ lipogenic capacity in the absence of glucose, or in the presence of the nonmetabolizable glucose analog 3-O-methylglucose. Upon replacing glucose with 2-deoxyglucose (1 mM), a glucose analog that undergoes phosphorylation to 2-deoxyglucose-6-phosphate with no further metabolism, vanadate was nearly as potent as with glucose in elevating lipogenic capacity. Vanadate was superior to insulin in increasing glucose-6-phosphate level in fasted-adipose explants. Adipose glucose-6-phosphatase activity was inhibited by vanadate (IC₅₀ = 7.0 ± 0.4 µM).

We have concluded that glucose-6-phosphate is the key metabolite of glucose involved in the transcriptionally regulated elevation of lipogenic capacity of fasted adipose explants. Vanadate has a more profound effect than insulin, as it elevates glucose-6-phosphate to higher levels and the subsequent increase in lipogenic capacity is four to five times greater than that induced by insulin. The mechanism involved is the combined action of vanadate in enchancing glucose entry and in inhibiting dephosphorylation of endogenously formed glucose-6-phosphate. The latter effect is not exerted by insulin.

This article has been cited by other articles:

				G. Banhegyi, M. Csala, and A. Benedetti Hexose-6-phosphate dehydrogenase: linking endocrinology and metabolism in the endoplasmic reticulum J. Mol. Endocrinol., April 1, 2009; 42(4): 283 - 289. [Abstract] [Full Text] [PDF]

				H. Mulder, M. Sorhede-Winzell, J. A. Contreras, M. Fex, K. Strom, T. Ploug, H. Galbo, P. Arner, C. Lundberg, F. Sundler, et al. Hormone-sensitive Lipase Null Mice Exhibit Signs of Impaired Insulin Sensitivity whereas Insulin Secretion Is Intact J. Biol. Chem., September 19, 2003; 278(38): 36380 - 36388. [Abstract] [Full Text] [PDF]

				Q. Sun, N. Sekar, I. Goldwaser, E. Gershonov, M. Fridkin, and Y. Shechter Vanadate restores glucose 6-phosphate in diabetic rats: a mechanism to enhance glucose metabolism Am J Physiol Endocrinol Metab, August 1, 2000; 279(2): E403 - E410. [Abstract] [Full Text] [PDF]